期刊文献+

角蛋白在肿瘤诊断及预后中的应用 被引量:1

Application of keratins in cancer diagnosis and prognosis
原文传递
导出
摘要 角蛋白是上皮细胞的骨架蛋白,可参与调控肿瘤细胞的凋亡耐受、生长及迁移,与肿瘤发生密切相关。有的角蛋白在肿瘤患者血清中的水平升高或高表达于肿瘤组织中,在临床上被广泛用于肿瘤的诊断;有的角蛋白的表达与肿瘤患者预后呈负相关,可作为肿瘤预后标志物。进一步阐明角蛋白联合其他标志物检测对肿瘤诊断及预后判断的价值,将为角蛋白应用于临床肿瘤诊断与预后评估提供理论依据。 Keratins are cytoskeleton proteins,which are involved in apoptotic resistance,growth and migration of cancer cells.The levels of some keratins are elevated in the serum of patients with cancers,or highly expressed in cancer tissues,and they are widely used in the diagnosis of tumor in clinic.The expressions of some keratins are negatively correlated with the prognosis of patients with cancers,and can be used as prognostic markers.Further clarifying the diagnostic and prognostic value of keratins combined with other markers detection can provide theoretical basis for the application of keratins in diagnosis and prognostic assessment of cancers.
作者 任梦 高燕 陈琪 岳文涛 Ren Meng;Gao Yan;Chen Qi;Yue Wentao(Central Laboratory,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China)
出处 《国际肿瘤学杂志》 CAS 2020年第6期360-363,共4页 Journal of International Oncology
基金 北京市科技计划(Z181100001718193)。
关键词 肿瘤 角蛋白质类 致癌作用 诊断 预后 Neoplasms Keratins Carcinogenesis Diagnosis Prognosis
  • 相关文献

二级参考文献34

  • 1Brzeziaflska E, Dutkowska A, Antczak A. The significance ofepigenetic alterations in lung carcinogenesis. Mol Biol Rep, 2013, 40(1):309-325.
  • 2Linder S, Olofsson MH, Herrmann R, et al. Utilization of cytokeratin-based biomarkers for pharmacadynamie studies. Expert Rev Mol Diagn, 2010,10(3): 353-359.
  • 3Weng YR, Cui Y, Fang JY. Biological functions of cytokeratin 18 in cancer.Mol Cancer Res, 2012,10(4): 485-493.
  • 4Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary timors. Hum Pathol, 2001,33(9): 921-926.
  • 5Rekhtman N, Ang DC, Sima CS, et al. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Mad Pathol, 2011,24(10):1348-1359.
  • 6Chen Y, Cui T, Yang L. The diagnostic value of eytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer. Ontology, 2011,80(5-6):333-340.
  • 7Khayyaia S, Yun S, Pasha T, et al.Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol, 2009, 37(3):178-183.
  • 8Warth A, Muley T, Herpel E, et aL Large-scale comparative analyses of immunomarkcrs for diagnostic subtyping of non-small- cell lung cancer biopsies.Histopathology, 2012, 61(6):1017-1025.
  • 9Masai K, Tsuta K, Kawago M, et al. Expression of SCluamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol, 2013, 21(4):292-297.
  • 10杨艳,潘秦镜,腾茂芳,李中林,赵琳琳,韩迺珺,高燕宁,曹箭.相关蛋白标记物辅助液基薄层细胞检测纤维支气管镜刷片细胞学肺癌分型诊断的探讨[J].中华肿瘤杂志,2008,30(8):616-619. 被引量:5

共引文献90

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部